Menke Andy, Fernández-Real José Manuel, Muntner Paul, Guallar Eliseo
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
BMC Cardiovasc Disord. 2009 Aug 3;9:34. doi: 10.1186/1471-2261-9-34.
Several studies have examined the association of biomarkers of iron metabolism with measures of carotid artery atherosclerosis, with inconsistent results. Few studies, however, have evaluated the association between biomarkers of iron metabolism and peripheral arterial disease (PAD). The purpose of this study is to examine the association of ferritin and transferrin saturation with PAD.
Serum ferritin, transferrin saturation, and PAD, defined as having an ankle-brachial blood pressure index <0.9, were measured in 1,631 men and 1,031 postmenopausal women participating in the 19992002 National Health and Nutrition Examination Survey (NHANES).
The multivariable adjusted odds ratios (95% confidence interval) for PAD associated with a two-fold increase in serum ferritin and transferrin saturation were 1.18 (1.001.41) and 1.45 (0.832.51), respectively, for men and 1.04 (0.871.25) and 1.55 (0.982.45), respectively, for women. After stratifying by cholesterol levels, the multivariable adjusted odds ratios (95% confidence intervals) for PAD associated with a two-fold increase in ferritin and transferrin saturation was 1.04 (0.781.39) and 0.73 (0.351.50), respectively, for men with total cholesterol <200 mg/dL and 1.30 (0.991.72) and 2.59 (0.996.78), respectively, for men with total cholesterol >or= 200 mg/dL (p-value for interaction was 0.58 for ferritin and 0.08 for transferrin saturation). After stratifying by cholesterol levels, the multivariable adjusted odds ratios (95% confidence intervals) for PAD associated with a two-fold increase in ferritin and transferrin saturation was 0.66 (0.411.05) and 0.75 (0.441.28), respectively, for women with total cholesterol <200 mg/dL, and 1.20 (0.951.51) and 2.07 (1.014.22), respectively, for women with total cholesterol >or= 200 mg/dL (p-value for interaction was 0.05 for ferritin and 0.02 for transferrin saturation).
In this large nationally representative sample of men and postmenopausal women, we found a modest association of ferritin and transferrin saturation with PAD, particularly among those with high cholesterol levels.
多项研究探讨了铁代谢生物标志物与颈动脉粥样硬化指标之间的关联,但结果并不一致。然而,很少有研究评估铁代谢生物标志物与外周动脉疾病(PAD)之间的关联。本研究旨在探讨铁蛋白和转铁蛋白饱和度与PAD之间的关联。
在参与1999 - 2002年美国国家健康与营养检查调查(NHANES)的1631名男性和1031名绝经后女性中,测量血清铁蛋白、转铁蛋白饱和度以及定义为踝臂血压指数<0.9的PAD。
血清铁蛋白和转铁蛋白饱和度增加两倍时,与PAD相关的多变量调整优势比(95%置信区间),男性分别为1.18(1.00 - 1.41)和1.45(0.83 - 2.51),女性分别为1.04(0.87 - 1.25)和1.55(0.98 - 2.45)。按胆固醇水平分层后,总胆固醇<200 mg/dL的男性中,铁蛋白和转铁蛋白饱和度增加两倍与PAD相关的多变量调整优势比(95%置信区间)分别为1.04(0.78 - 1.39)和0.73(0.35 - 1.50),总胆固醇≥200 mg/dL的男性分别为1.30(0.99 - 1.72)和2.59(0.99 - 6.78)(铁蛋白交互作用的p值为0.58,转铁蛋白饱和度为0.08)。按胆固醇水平分层后,总胆固醇<200 mg/dL的女性中,铁蛋白和转铁蛋白饱和度增加两倍与PAD相关的多变量调整优势比(95%置信区间)分别为0.66(0.41 - 1.05)和0.75(0.44 - 1.28),总胆固醇≥200 mg/dL的女性分别为1.20(0.95 - 1.51)和2.07(1.01 - 4.22)(铁蛋白交互作用的p值为0.05,转铁蛋白饱和度为0.02)。
在这个具有全国代表性的大型男性和绝经后女性样本中,我们发现铁蛋白和转铁蛋白饱和度与PAD存在适度关联,尤其是在高胆固醇水平人群中。